NOVONIX Limited is a battery materials and technology company. The Company manufactures battery cell testing equipment, is growing its high-performance synthetic graphite material manufacturing operations, and has developed a patented all-dry, zero-waste cathode synthesis process. The Company's segments include Battery Materials and Battery Technology. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment, performs consulting services and carries out research and development in battery development (inclusive of cathode technology). The Company's Riverside facility, located in Chattanooga, Tennessee, is a production site focused on high-performance synthetic graphite for the battery sector in North America. The Company's battery technology solutions include battery testing equipment and research and development services. It provides ultra-high precision coulometry systems.
Company Information
About this company
Key people
Michael O'Kronley
Chief Executive Officer, Managing Director, Director
Robert Long
Chief Financial Officer
Darcy Macdougald
Chief Operating Officer
Rashda Buttar
Chief Legal & Administrative Officer
Suzanne M. Yeates
Company Secretary
Ronald C. Edmonds
Independent Chairman of the Board
Anthony George Bellas
Non-Executive Independent Deputy Chairman of the Board
Nicholas Liveris
Non-Executive Director
Robert J. Natter
Non-Executive Director
Suresh Vaidyanathan
Non-Executive Director
Click to see more
Key facts
- Shares in issue0.00
- EPICNVX
- ISINUS67010L1008
- LocationAustralia
- SectorTechnology
- IndustryElectronic Instr. & Controls
- Market cap$290.43m
- Employees202
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.